Drug
selpercatinib
Marketed as RETEVMO.
Generic name
selpercatinib
Brand names
RETEVMO
First FDA approval
2020-05-08
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA213246 | RETEVMO | 2020-05-08 | ELI LILLY AND CO |
Manufacturers
ELI LILLY AND CO
Frequently asked questions
When was selpercatinib FDA approved?
Earliest FDA approval on record: 2020-05-08.
What brand names are sold as selpercatinib?
RETEVMO.
Sources
Appeal a selpercatinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com